| __timestamp | ADMA Biologics, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 13673000 |
| Thursday, January 1, 2015 | 7015946 | 14358000 |
| Friday, January 1, 2016 | 7688238 | 12203000 |
| Sunday, January 1, 2017 | 6229587 | 18125000 |
| Monday, January 1, 2018 | 3926120 | 17071000 |
| Tuesday, January 1, 2019 | 2343848 | 20018000 |
| Wednesday, January 1, 2020 | 5907013 | 32788000 |
| Friday, January 1, 2021 | 3646060 | 44966000 |
| Saturday, January 1, 2022 | 3613764 | 311681000 |
| Sunday, January 1, 2023 | 3300000 | 77707000 |
Infusing magic into the data realm
In the competitive landscape of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Lantheus Holdings, Inc. and ADMA Biologics, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Lantheus Holdings consistently outspent ADMA Biologics, with a peak in 2022 where their R&D expenses were nearly 900% higher than ADMA's. This significant investment underscores Lantheus's strategic focus on innovation, particularly in recent years. Meanwhile, ADMA Biologics has maintained a steady, albeit smaller, R&D budget, reflecting a more conservative approach. The data reveals a clear trend: Lantheus Holdings is prioritizing innovation at a much larger scale, potentially positioning itself for greater breakthroughs in the biotech sector. As the industry evolves, these spending patterns may well dictate future market leadership.
Research and Development Expenses Breakdown: Zoetis Inc. vs Lantheus Holdings, Inc.
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc.
Research and Development Investment: Biogen Inc. vs Lantheus Holdings, Inc.
R&D Spending Showdown: Lantheus Holdings, Inc. vs Madrigal Pharmaceuticals, Inc.
Comparing Innovation Spending: Lantheus Holdings, Inc. and Alpine Immune Sciences, Inc.
Research and Development Investment: Lantheus Holdings, Inc. vs TG Therapeutics, Inc.
R&D Insights: How Lantheus Holdings, Inc. and Amicus Therapeutics, Inc. Allocate Funds
Comparing Innovation Spending: Grifols, S.A. and ADMA Biologics, Inc.
Research and Development Investment: ADMA Biologics, Inc. vs Xenon Pharmaceuticals Inc.
Research and Development Investment: ADMA Biologics, Inc. vs Protagonist Therapeutics, Inc.
Research and Development: Comparing Key Metrics for ADMA Biologics, Inc. and Xencor, Inc.